The December sale of biotech firm Élan to Perrigo brought to an end one of last year’s most watched hostile takeover sagas, and has revealed the Irish Takeover Panel’s unwavering approach to its rules
Unlock this content.
The content you are trying to view is exclusive to our subscribers.